Baxion
Screening
Tags
Alerts
Theme
Kala Bio, Inc.
KALA
·
NASDAQ
·
$2.17
Share Price as of 11/2
·
$48M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/19/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
04/15/26
10-Q
Q3 ended 09/30/25
11/19/25
10-Q
Q2 ended 06/30/25
08/08/25
Disclosures
Filter
8-K
Current report
09/10/26
8-K
Current report
09/09/26
8-K
Current report
08/28/26
8-K
Current report
07/23/26
8-K
Current report
05/07/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
07/22/26
S-3/A
Shelf registration (amended)
06/12/26
S-3
Shelf registration
05/07/26
424B3
Prospectus
02/17/26
S-3
Shelf registration
02/10/26
Proxies
Filter
DEF 14A
Definitive proxy
09/24/26
PRE 14A
Preliminary proxy
09/11/26
DEFA14A
Additional proxy materials
01/26/26
DEFA14A
Additional proxy materials
01/06/26
DEF 14A
Definitive proxy
12/30/25
Ownership
Filter
SC 13G
Beneficial ownership
10/19/26
SC 13D/A
Beneficial ownership (amended)
07/02/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
144
Proposed sale of securities
03/17/26
144
Proposed sale of securities
03/12/26
Other
Filter
NT 10-Q
Late filing notification (10-Q)
08/14/26
EFFECT
Request for effectiveness
06/25/26
NT 10-K
Late filing notification (10-K)
03/31/26
D
D
03/17/26
EFFECT
Request for effectiveness
02/17/26
Latest Filings
Filter
DEF 14A
Definitive proxy
09/24/26
PRE 14A
Preliminary proxy
09/11/26
8-K
Current report
09/10/26
8-K
Current report
09/09/26
8-K
Current report
08/28/26
Ownership
Filter
SC 13G
Beneficial ownership
10/19/26
SC 13D/A
Beneficial ownership (amended)
07/02/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
144
Proposed sale of securities
03/17/26
144
Proposed sale of securities
03/12/26